We developed a comprehensive forecasting model to support business planning and clinical development

Client challenge

Accurately forecast patient numbers, sales figures and patient shares for eight TPPs out to 2040, in order to support business planning

InterPhase approach

Develop a comprehensive, interactive, bottom-up forecasting model, implementing customisable market and product dynamics and advanced financial inputs

Capability to model up to 8 competitors incorporated, future-proofing model against market developments


8 x TPPs

4 x competitor launch scenarios

7 markets: US, JP, EU5


A fully interactive and modifiable forecasting model, delivered to schedule despite several changes in scope during project

A detailed slide presentation including gross & net revenue projections, cash flows, patient numbers, drug volumes and patient numbers provided a comprehensive foundation to guide the future clinical development of the client’s product